CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 33 enrolled
Drug / intervention
Seaweed and Soy Protein +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01204957
NCT01204957Phase 2Completed
CompareCT.gov

Brown Seaweed as a Breast Cancer Preventive

University of South Carolina·interventional·Posted Sep 17, 2010·Updated Apr 6, 2015

In Brief

A Phase 2 clinical trial evaluating Seaweed and Soy Protein and Placebo and Soy Protein for Breast Cancer. Completed, enrolled 33 participants across 1 site.

Detailed Summary

Japanese postmenopausal women in Japan have about one ninth the rate of American postmenopausal women. Rates of breast cancer double even after just ten years among Japanese women who migrate to the US. Diet is thought to be an important factor, and the investigators were interested in whether dietary seaweed, with and without soy supplements, could influence known biomarkers of breast cancer risk in American women.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesUnited States
CollaboratorsSusan G. Komen Breast Cancer Foundation

Timeline

Phase 2CompletedFinished
199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 17, 2010
Enrollment StartOct 1, 1998
Primary CompletionMar 1, 1999
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 15.8 years ago

Interventions

Seaweed and Soy Proteindietary

5 g/d Seaweed for 6 wks, followed by 5 g/d Seaweed + Soy Protein for 1 wk

Placebo and Soy Proteindietary

5 g/d Placebo for 6 wks, followed by 5 g/d Placebo + Soy Protein for 1 wk